Vertex Pharmaceuticals | VRTX - Interest Income


Vertex Pharmaceuticals reported $118.4M in Interest Income for its fiscal quarter ending in September of 2026.





Interest Income Change Date
AbbVie USD 67M 5M Jun/2026
Acadia Pharmaceuticals USD 7.99M 65K Jun/2026
Agios Pharmaceuticals USD 9.73M 1.06M Jun/2026
Alnylam Pharmaceuticals USD 28.14M 1.54M Jun/2026
Arrowhead Research USD 16.93M 66K Jun/2026
Biogen USD 25.3M 12.6M Jun/2026
BioMarin Pharmaceutical USD 4.63M 5.85M Sep/2026
Gilead Sciences USD 45M 50M Jun/2026
Incyte USD 38.12M 4.43M Jun/2026
Insmed USD 765K 55K Sep/2024
Ionis Pharmaceuticals USD -0.66 0.29 Dec/2024
J&J USD 0.09 2.18 Sep/2026
Merck USD 35M 0 Jun/2026
Moderna USD 67M 5M Jun/2026
Pfizer USD 0.56 0.6 Sep/2026
Puma Biotechnology USD 0.41 0.5 Sep/2024
Regeneron Pharmaceuticals USD 183.3M 200K Jun/2026
Sanofi EUR 77M 17M Jun/2026
Sarepta Therapeutics USD 7.16M 160K Jun/2026
Ultragenyx Pharmaceutical USD 5M 1000K Jun/2026
United Therapeutics USD 31.5M 10.3M Jun/2026
Vertex Pharmaceuticals USD 118.4M 2.2M Sep/2026